ReviewCancers2021

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma.

Pier Francesco Ferrucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.